Health
Beckman Coulter Launches Semi-Quantitative Access SARS-CoV-2 IgG II Antibody Test – HospiMedica
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patient’s relative level of antibodies in response to…
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patients relative level of antibodies in response to a previous SARS-CoV-2 infection. The assays new capabilities enable clinicians to establish a baseline to evaluate an individuals immune response to the SARS-CoV-2 virus based on a numerical value and assess relative changes of an individuals immune response to the virus over time. The assay may also help researchers as they begin to understand…
-
General13 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News16 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News22 hours agoQueensland Rail retires iconic electric train fleet after more than four decades
-
Business18 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth